Immunogenic anti-inflammatory compositions
AssigneeQu Biologics Inc.
InventorsHarold David Gunn, Salim Dhanji, Brett Anthony Premack, Michael Tak Huai Chow
Life of this patent
Estimating the term…
Loading patent…
AssigneeQu Biologics Inc.
InventorsHarold David Gunn, Salim Dhanji, Brett Anthony Premack, Michael Tak Huai Chow
Estimating the term…
The invention provides methods of formulating an anti-inflammatory composition for treating inflammatory conditions in a specific organ or tissue. The method involves selecting at least one pathogen that is pathogenic in the specific organ or tissue; producing an antigenic composition comprising antigenic determinants that together are specific for the pathogen; and formulating the antigenic composition for administration as an anti-inflammatory composition capable of eliciting an anti-inflammatory response in the specific organ or tissue. In embodiments of the invention the pathogen may be an endogenous pathogen, such as an endogenous bacterial pathogen. The pathogen may be an exogenous pathogen, such as a bacterial pathogen, viral pathogen, a fungal pathogen, or a helminth pathogen.
1-88. (canceled)
A method for formulating an immunogenic composition for treating arthritis that is symptomatic in a joint of a human patient, comprising:
A method for treating a human patients for arthritis that is symptomatic in a joint, comprising administering to the patient a medicament comprising an effective amount of an antigenic composition comprising antigenic determinants that together are specific for at least one pathogen, wherein the pathogen is selected on the basis that the pathogen is pathogenic in the joint.
A method of selecting an antigenic composition for treating a patient for arthritis that is symptomatic in a joint, the method comprising:
113-114. (canceled)
Dependencies are inferred from the claim text.